1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Tuberculosis, Cardiovascular: new trials by email Literature Review of Tuberculosis, Cardiovascular trials Research Report on Tuberculosis, Cardiovascular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis high dose Rifampicin (RIF) - Tuberculous Pericarditis, HIV Status | Phase 2 | Completed | University of Cape Town | 52 | 2022-01-10 | 2026-09-01 |
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Cardiovascular Diseases (1) · Cardiovascular Infections (1) · Gram-Positive Bacterial Infections (1) · Heart Diseases (1) · Infections (1) · Mycobacterium Infections (1) · Pericarditis (1) · Tuberculosis (1) · Tuberculosis, Extrapulmonary (1)
Rifampin (1)
South Africa (1)